Gary Gaglione
Overview
Gary Gaglione received an average of $393K in total compensation, including $192K in salary, at Matinas BioPharma Holdings between 2017 and 2018.
Source: SEC filing on September 24, 2019.
Related executives
We found nine more executives who work or worked at Matinas BioPharma Holdings.
Jerome Jabbour
Matinas BioPharma Holdings
Chief Executive Officer
James Ferguson
Matinas BioPharma Holdings
Chief Medical Officer
Theresa Matkovits
Matinas BioPharma Holdings
Chief Development Officer
Keith Kucinski
Matinas BioPharma Holdings
Chief Financial Officer
Roelof Rongen
Matinas BioPharma Holdings
Chief Executive Officer
Raphael Mannino
Matinas BioPharma Holdings
Chief Scientific Officer
Dominick DiPaolo
Matinas BioPharma Holdings
Former Senior Vice President, Quality and Regulatory Compliance
Douglas Kling
Matinas BioPharma Holdings